文献速递衰弱、肌少症与跌倒老年综合评估老年慢病共病管理

肌少症与老年康复住院患者出院后3个月及1年死亡率相关:RESORT研究

Sarcopenia is associated with 3-month and 1-year mortality in geriatric rehabilitation inpatients: RESORT.
PubMed 文献 · Age Ageing · 2021-01-01

RESORT前瞻性队列纳入1406例老年康复住院患者(中位年龄83.0岁,58%女性),按EWGSOP、EWGSOP2和AWGS 2019标准评估入院时肌少症及其组分与出院后3个月和1年全因死亡率的关联。结果显示肌少症与女性3个月和1年死亡率显著相关,与男性3个月和1年死亡率也显著相关(EWGSOP2、AWGS 2019);低肌肉量和低肌力分别与不同时间点死亡率显著相关。

要点

  • 入院时肌少症与老年康复患者出院后3个月和1年死亡率显著相关。
  • 女性低肌肉量与3个月和1年死亡率显著相关,低肌力与1年死亡率显著相关。
  • 男性低肌肉量与3个月和1年死亡率显著相关,低肌力与3个月死亡率显著相关。

核心结论

  • 入院时肌少症、低肌肉量和低肌力与老年康复住院患者出院后死亡率显著升高相关。
  • 研究提示临床实践中应测量肌肉量和肌力以识别高风险患者。

研究设计与样本

  • RESORT为观察性前瞻性纵向队列,纳入老年康复住院患者n=1406,中位年龄83.0岁(IQR 77.4-88.2),58%为女性。
  • 采用性别分层Cox比例风险分析,评估入院时肌少症及其组分与出院后3个月和1年全因死亡率的关联。

主要发现

  • 肌少症(EWGSOP、EWGSOP2和AWGS 2019标准)与女性3个月和1年死亡率显著相关。
  • 肌少症(EWGSOP2、AWGS 2019标准)与男性3个月和1年死亡率显著相关。
  • 女性低肌肉量(三种标准)与3个月和1年死亡率显著相关,低肌力(三种标准)与1年死亡率显著相关。
  • 男性低肌肉量(EWGSOP2、AWGS 2019标准)与3个月和1年死亡率显著相关,低肌力(EWGSOP2、AWGS 2019标准)与3个月死亡率显著相关。
  • 因身体功能正常患者中死亡事件少于5例,未分析身体功能与死亡率的关联。

关键数值与推荐

  • 肌少症诊断采用EWGSOP、EWGSOP2和AWGS 2019标准。
  • 结局为出院后3个月和1年全因死亡率,采用性别分层Cox比例风险分析。

临床怎么用

  • 对老年康复住院患者入院时评估肌少症,尤其关注肌肉量和肌力。
  • 识别低肌肉量或低肌力患者可能有助于判断出院后3个月和1年死亡风险。

局限性

  • 身体功能与死亡率的关联因正常身体功能患者中死亡事件少于5例而未分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sarcopenia is highly prevalent in geriatric rehabilitation patients and can worsen prognosis. This study aimed to investigate the association of sarcopenia and components of sarcopenia with 3-month and 1-year post-discharge mortality in geriatric rehabilitation inpatients. METHODS: REStORing health of acutely unwell adulTs (RESORT) is an observational, prospective longitudinal cohort of geriatric rehabilitation inpatients. Sex-stratified Cox proportional-hazards analyses were used to associate sarcopenia (and its components) at admission, by the European Working Group on Sarcopenia in Older People (EWGSOP, EWGSOP2) and the Asian Working Group for Sarcopenia 2019 (AWGS 2019), with 3-month and 1-year post-discharge all-cause mortality. RESULTS: Patients (n = 1,406) had a median interquartile ranges [IQR] age of 83.0 [77.4-88.2] years (58% females). Sarcopenia was significantly associated with 3-month and 1-year mortality in females (EWGSOP, EWGSOP2 and AWGS 2019) and males (EWGSOP2, AWGS 2019). In females, low muscle mass (EWGSOP, EWGSOP2 and AWGS 2019) was significantly associated with 3-month and 1-year mortality; low muscle strength (EWGSOP, EWGSOP2 and AWGS 2019) was significantly associated with 1-year mortality. For males, low muscle mass (EWGSOP2, AWGS 2019) was significantly associated with 3-month and 1-year mortality; low muscle strength (EWGSOP2, AWGS 2019) was significantly associated with 3-month mortality. The association between physical performance with mortality was not analysed due to less than five events (death) in patients with normal physical performance. CONCLUSIONS: Sarcopenia, low muscle mass and low muscle strength at admission are associated with a significantly higher risk of mortality post-discharge from geriatric rehabilitation, highlighting the need to measure muscle mass and strength in clinical practice.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Xu J, Reijnierse EM, Pacifico J, et al. Sarcopenia is associated with 3-month and 1-year mortality in geriatric rehabilitation inpatients: RESORT. Age Ageing. 2021. PMID: 34260683. doi:10.1093/ageing/afab134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。